Trial no.:
|
PACTR202101805407126 |
Date of Approval:
|
12/01/2021 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Influence of Hyperbaric Oxygen Therapy on Sensorimotor Functions in Diabetic Peripheral Neuropathy |
Official scientific title |
Influence of Hyperbaric Oxygen Therapy on Sensorimotor Functions in Diabetic Peripheral Neuropathy |
Brief summary describing the background
and objectives of the trial
|
Hyperbaric oxygen therapy (HBOT) involves breathing 100 % oxygen in a pressurized room or tube and is a well-established rst choice treatment for decompression sickness and gas poisoning. Although HBOT is widely used for the treatment of various clinical diseases, multiple studies indicated its benet in conditions of vascular pathology with conrmed effect on healing of chronic wounds, prevention of minor or major amputations especially in diabetic patients |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Nutritional, Metabolic, Endocrine |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Hyperbaric Oxygen Therapy |
Anticipated trial start date |
06/01/2021 |
Actual trial start date |
|
Anticipated date of last follow up |
31/03/2021 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
40 |
Actual target sample size (number of participants) |
|
Recruitment status |
Recruiting |
Publication URL |
|
|